Cargando…
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
Background. Administration of convalescent plasma, serum, or hyperimmune immunoglobulin may be of clinical benefit for treatment of severe acute respiratory infections (SARIs) of viral etiology. We conducted a systematic review and exploratory meta-analysis to assess the overall evidence. Methods. H...
Autores principales: | Mair-Jenkins, John, Saavedra-Campos, Maria, Baillie, J. Kenneth, Cleary, Paul, Khaw, Fu-Meng, Lim, Wei Shen, Makki, Sophia, Rooney, Kevin D., Nguyen-Van-Tam, Jonathan S., Beck, Charles R., Mateus, Ana L. P., Reuter, Simone, Shin, Jinho, Xu, Xiaolin, Pereyaslov, Dmitriy, Papieva, Irina, Tegnell, Anders, Englund, Hélène, Elfving, Åsa, Cox, Rebecca, Mohn, Kristin Greve-Isdahl, Jenkins, Yingjie Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264590/ https://www.ncbi.nlm.nih.gov/pubmed/25030060 http://dx.doi.org/10.1093/infdis/jiu396 |
Ejemplares similares
-
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
por: Chavda, Vivek P., et al.
Publicado: (2023) -
Cochrane corner: convalescent plasma or hyperimmune immunoglobulin for people with COVID-19
por: Nnaji, Chukwudi Arnest, et al.
Publicado: (2020) -
Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?
por: Basic-Jukic, Nikolina
Publicado: (2020) -
Production of anti‐SARS‐CoV‐2 hyperimmune globulin from convalescent plasma
por: Vandeberg, Peter, et al.
Publicado: (2021) -
Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma
por: Ali, Shaukat, et al.
Publicado: (2021)